Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Interest ReceivablesChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Share-based Compensation: 2024-2025

  • Abivax's Share-based Compensation fell 18.15% to -$7.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.9 million, marking a year-over-year change of. This contributed to the annual value of $21.6 million for FY2024, which is 145.58% up from last year.
  • Latest data reveals that Abivax reported Share-based Compensation of -$7.1 million as of Q2 2025, which was down 243.69% from $4.9 million recorded in Q1 2025.
  • In the past 5 years, Abivax's Share-based Compensation registered a high of $6.3 million during Q1 2024, and its lowest value of -$7.1 million during Q2 2025.
  • Its 2-year average for Share-based Compensation is -$475,291, with a median of -$532,989 in 2024.
  • Data for Abivax's Share-based Compensation shows a maximum YoY dropped of 21.11% (in 2025) over the last 5 years.
  • Over the past 2 years, Abivax's Share-based Compensation (Quarterly) stood at -$6.0 million in 2024, then fell by 18.15% to -$7.1 million in 2025.
  • Its last three reported values are -$7.1 million in Q2 2025, $4.9 million for Q1 2025, and -$6.0 million during Q2 2024.